GeoVax Labs, Inc.
GOVX
$0.72
$0.000.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 852.30K | 2.49M | 3.35M | 6.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 852.30K | 2.49M | 3.35M | 6.14M |
| Cost of Revenue | 15.05M | 16.67M | 18.12M | 22.74M | 25.09M |
| Gross Profit | -15.05M | -15.82M | -15.63M | -19.38M | -18.95M |
| SG&A Expenses | 5.48M | 5.69M | 6.01M | 6.16M | 6.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.53M | 22.36M | 24.13M | 28.90M | 31.17M |
| Operating Income | -20.53M | -21.51M | -21.64M | -25.54M | -25.02M |
| Income Before Tax | -20.43M | -21.37M | -21.46M | -25.31M | -24.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.43 | -21.37 | -21.46 | -25.31 | -24.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.43M | -21.37M | -21.46M | -25.31M | -24.81M |
| EBIT | -20.53M | -21.51M | -21.64M | -25.54M | -25.02M |
| EBITDA | -20.47M | -21.44M | -21.57M | -25.47M | -24.94M |
| EPS Basic | -13.92 | -21.69 | -30.28 | -49.15 | -64.06 |
| Normalized Basic EPS | -8.70 | -13.56 | -18.92 | -30.72 | -40.04 |
| EPS Diluted | -13.92 | -21.69 | -30.28 | -49.15 | -64.06 |
| Normalized Diluted EPS | -8.70 | -13.56 | -18.92 | -30.72 | -40.04 |
| Average Basic Shares Outstanding | 9.12M | 5.17M | 3.64M | 2.29M | 1.73M |
| Average Diluted Shares Outstanding | 9.12M | 5.17M | 3.64M | 2.29M | 1.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |